Reauthorizations Cause Sponsor Angst For PREA, BPCA Studies, GAO Finds

The regular reauthorization of PREA and BPCA, when coupled with the long review horizon for pediatric studies at FDA, could be hindering sponsors’ willingness to conduct the trials, according to a Government Accountability Office Report.